Results 201 to 210 of about 43,347 (215)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review

Biochemical Pharmacology, 2014
Judith M Rollinger, Elke H. Heiß, Eva-Maria Pferschy-Wenzig   +2 more
exaly  

Expression of peroxisome-proliferator activated receptor-gamma (PPARγ) and the PPARγ co-activator, PGC-1, in human breast cancer correlates with clinical outcomes

International Journal of Cancer, 2003
Wen Jiang, Robert Mansel, Anthony Douglas-Jones   +2 more
exaly  

Molecular cloning, characterization and expression analysis of PPAR gamma in the orange-spotted grouper () after the challenge

Fish and Shellfish Immunology, 2015
Xiaohong Huang, Shengwei Luo, Qiwei Qin
exaly  

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model

International Journal of Molecular Sciences, 2020
Akira Shimizu, Takeshi Arima, Masaaki Uchiyama   +2 more
exaly  

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) as a Target for Concurrent Management of Diabetes and Obesity-Related Cancer

Current Pharmaceutical Design, 2017
Fudi Wang, Mustapha Umar Imam
exaly  

Fatty acids, eicosanoids and PPAR gamma

European Journal of Pharmacology, 2016
Rachel Marion-Letellier
exaly  

Formulation of PPAR-gamma agonist as surface modified PLGA nanoparticles for non-invasive treatment of diabetic retinopathy: in vitro and in vivo evidences

Heliyon, 2020
Umesh D Laddha, Sanjay Kshirsagar
exaly  

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ as a Novel Target for Prostate Cancer

Investigational New Drugs, 2002
Philip W. Kantoff
exaly  

Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity

Oncogene, 2005
Susan M Fischer, L M Leesnitzer
exaly  

Implications of the endogenous PPAR-gamma ligand, 15-deoxy-delta-12, 14-prostaglandin J2, in diabetic retinopathy

Life Sciences, 2016
Tapan Behl, Anita Kotwani
exaly